Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study.

ABSTRACT:

Background & aims

Whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a risk factor for splanchnic vein thrombosis (SVT) is unknown. This study aims to assess the impact of SARS-CoV-2 infection on the presentation and prognosis of recent SVT and to identify specific characteristics of SARS-CoV-2-associated SVT.

Methods

This is a retrospective study collecting health-related data of 27 patients presenting with recent SVT in the context of SARS-CoV-2 infection in 12 Vascular Liver Disease Group (VALDIG) centres and in comparison with 494 patients with recent SVT before the SARS-CoV-2 pandemic.

Results

Twenty-one patients with SARS-CoV-2 had portal vein thrombosis with or without thrombosis of another splanchnic vein, two had superior mesent

SUBMITTER: Deltenre P 

PROVIDER: S-EPMC10570588 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature